Sexual motivation: problem solved and new problems introduced

References

[1] Pfaff DW, editor. The physiological mechanisms of motivation. Heidelberg: Springer-Verlag, 1982.10.1007/978-1-4612-5692-2Search in Google Scholar

[2] Pfaff D, Tabansky I, Haubensak W. Tinbergen’s challenge for the neuroscience of behavior. Proc Natl Acad Sci USA. 2019;116:9704–10.10.1073/pnas.1903589116Search in Google Scholar

[3] Pfaff DW. How the vertebrate brain regulates behavior. Cambridge, MA: Harvard University Press, 2017.10.4159/9780674978751Search in Google Scholar

[4] Hull EM, Rodriguez-Manzo G. Male sexual behavior. In: Pfaff DW, editor. Hormones, brain and behavior. San Diego,CA: Academic Press/Elsevier; 2017;1 of 5:1–51.10.1016/B978-0-12-803592-4.00001-8Search in Google Scholar

[5] Rice ME. Closing in on what motivates motivation. Nature. 2019;570:40–3.10.1038/d41586-019-01589-6Search in Google Scholar

[6] Mohebi A, Pettibone JR, Hamid AA, Wong JT, Vinson LT, Patriarchi T, et al. Dissociable dopamine dynamics for learning and motivation. Nature. 2019;570:65–70.10.1038/s41586-019-1235-ySearch in Google Scholar

[7] Schultz W, Stauffer WR, Lak A. The phasic dopamine signal maturing: from reward via behavioural activation to formal economic utility. Curr Opin Neurobiol. 2017;43:139–48.10.1016/j.conb.2017.03.013Search in Google Scholar

[8] Horvitz JC. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience. 2000;96:651–62.10.1016/S0306-4522(00)00019-1Search in Google Scholar

[9] Choi WY, Campbell CM, Balsam PD, Horvitz JC. Effects of cortical and striatal dopamine D1 receptor blockade on cued versus noncued behavioral responses. Behav Neurosci. 2011;125:705–13.10.1037/a0025166Search in Google Scholar PubMed PubMed Central

[10] Agmo A, Yuabov M, Pfaff DW. Hormonal contributions to arousal and motivation. In: Coen C, editor. Encyclopedia of behavioral neuroscience. London: Academic Press/Elsevier, 2019.10.1016/B978-0-12-809324-5.21963-9Search in Google Scholar

[11] Pfaff DW, Rubin RT, Schneider JE, Head GA. Principles of hormone/behavior relations. San Diego, CA: Academic Press/Elsevier, 2018.10.1016/B978-0-12-802629-8.00007-3Search in Google Scholar

[12] McCall C, Singer T. The animal and human neuroendocrinology of social cognition, motivation and behavior. Nat Neurosci. 2012;15:681–8.10.1038/nn.3084Search in Google Scholar

[13] Persky H, Smith KD, Basu GK. Relation of psychologic measures of aggression and hostility to testosterone production in man. Psychosom Med. 1971;33:265–77.10.1097/00006842-197105000-00007Search in Google Scholar

[14] Mazur A, Lamb TA. Testosterone, status, and mood in human males. Horm Behav. 1980;14:236–46.10.1016/0018-506X(80)90032-XSearch in Google Scholar

[15] Celotti F, Melcangi RC, Negri-Cesi P, Poletti A. Testosterone metabolism in brain cells and membranes. J Steroid Biochem Mol Biol. 1991;40:673–8.10.1016/0960-0760(91)90289-HSearch in Google Scholar

[16] Jockenhövel F, Minnemann T, Schubert M, Freude S, Hübler D, Schumann C, et al. Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men. Eur J Endocrinol. 2009;160:815–9.10.1530/EJE-08-0830Search in Google Scholar PubMed

[17] Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 2004;89:2085–98.10.1210/jc.2003-032006Search in Google Scholar PubMed

[18] Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, et al. Testosterone Trials Investigators. Effects of testosterone treatment in older men. N Engl J Med. 2016;374:611–24.10.1056/NEJMoa1506119Search in Google Scholar PubMed PubMed Central

[19] Amanatkar HR, Chibnall JT, Seo BW, Manepalli JN, Grossberg GT. Impact of exogenous testosterone on mood: a systematic review and meta-analysis of randomized placebo-controlled trials. Ann Clin Psychiatry. 2014;26:19–32.Search in Google Scholar

[20] Herrmann WM, Beach RC. Psychotropic effects of androgens: a review of clinical observations and new human experimental findings. Pharmakopsychiatr Neuropsychopharmakol. 1976;9:205–19.10.1055/s-0028-1094494Search in Google Scholar PubMed

[21] Werner AA. The male climacteric. J Am Med Assoc. 1946;132:188–94.10.1001/jama.1946.02870390004002Search in Google Scholar PubMed

[22] Greenblatt RB, Nezhat C, Roesel RA, Natrajan PK. Update on the male and female climateric. J Am Geriatr Soc. 1979;27:481–90.10.1111/j.1532-5415.1979.tb01734.xSearch in Google Scholar PubMed

[23] Heinemann AJ, Zimmermann T, Vermeulen A, Thiel C. A new aging male’s symptom (AMS) rating scale. Aging Male. 1999;2:105–14.10.3109/13685539909003173Search in Google Scholar

[24] Wu CY, Yu TJ, Chen MJ. Age related testosterone level changes and male andropause syndrome. Chang Gung Med J. 2000;23:348–53.Search in Google Scholar

[25] Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, Perry HM 3rd. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49:1239–42.10.1053/meta.2000.8625Search in Google Scholar

[26] Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxf). 2000;53:703–11.10.1046/j.1365-2265.2000.01152.xSearch in Google Scholar

[27] Delhez M, Hansenne M, Legros JJ. Andropause and psychopathology: minor symptoms rather than pathological ones. Psychoneuroendocrinol. 2003;28:863–74.10.1016/S0306-4530(02)00102-6Search in Google Scholar

[28] Gooren LJ, Kruijver FP. Molec Cell Endocrinol. 2002;198:31–40.10.1016/S0303-7207(02)00366-0Search in Google Scholar

[29] Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, et al. Testosterone replacement therapy improves mood in hypogonadal men: a clinical research center study. J Clin Endocrinol Metab. 1996;81:3578–83.10.1210/jcem.81.10.8855804Search in Google Scholar

[30] Rubinow DR. Androgens, brain and behavior. Am J Psychiatry. 1996;153:974–84.10.1176/ajp.153.8.974Search in Google Scholar

[31] Seidman SN, Walsch BT. Testosterone and depression in aging men. Am J Geriatr Psychiatry. 1999;7:18–33.10.1097/00019442-199902000-00004Search in Google Scholar

[32] Schweiger U, Deuschle M, Weber B, Körner A, Lammers CH, Schmider J, et al. Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med. 1999;61:292–6.10.1097/00006842-199905000-00007Search in Google Scholar

[33] Kouri EM, Lukas SE, Pope, Jr HG, Oliva PS. Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug Alcohol Depend. 1995;40:73–9.10.1016/0376-8716(95)01192-7Search in Google Scholar

[34] Daly RC, Su TP, Schmidt PJ, Pickar D, Murphy DL, Rubinow DR. Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings. Arch Gen Psychiatry. 2001;58:172–7.10.1001/archpsyc.58.2.172Search in Google Scholar PubMed

[35] Dabbs JM, Karpas AE, Dyomina N, Juechter J, Roberts A. Experimental raising or lowering of testosterone level affects mood in normal men and women. Social Behav Personal. 2002;30:795–806.10.2224/sbp.2002.30.8.795Search in Google Scholar

[36] Pope HG Jr, Amiaz R, Brennan BP, Orr G, Weiser M, Kelly JF, et al. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol. 2010;30:126–34.10.1097/JCP.0b013e3181d207caSearch in Google Scholar PubMed

[37] Skakkebaek NE, Bancroft J, Davidson DW, Warner P. Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double-blind controlled study. Clin Endocrinol (Oxf). 1981;14:49–61.10.1111/j.1365-2265.1981.tb00364.xSearch in Google Scholar PubMed

[38] Vaughan C, Goldstein FC, Tenover JL. Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone. J Androl. 2007;28:875–82.10.2164/jandrol.107.002931Search in Google Scholar PubMed

[39] O’Connor DB, Archer J, Wu FC. Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study. J Clin Endocrinol Metab. 2004;89:2837–45.10.1210/jc.2003-031354Search in Google Scholar PubMed

[40] Mirdamadi A, Garakyaraghi M, Pourmoghaddas A, Bahmani A, Mahmoudi H, Gharipour M. Beneficial effects of testosterone therapy on functional capacity, cardiovascular parameters, and quality of life in patients with congestive heart failure. Biomed Res Int. 2014;2014:392432.10.1155/2014/392432Search in Google Scholar PubMed PubMed Central

[41] Howell SJ, Radford JA, Adams JE, Smets EM, Warburton R, Shalet SM. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clin Endocrinol (Oxf). 2001;55:315–24.10.1046/j.1365-2265.2001.01297.xSearch in Google Scholar PubMed

[42] Brockenbrough AT, Dittrich MO, Page ST, Smith T, Stivelman JC, Bremner WJ. Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease. Am J Kidney Dis. 2006;47:251–62.10.1053/j.ajkd.2005.10.022Search in Google Scholar PubMed

[43] Schiavi RC, White D, Mandeli J, Levine AC. Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction. Arch Sex Behav. 1997;26:231–41.10.1023/A:1024518730222Search in Google Scholar

[44] Bahrke MS, Yesalis CE, Wright JE. Psychological and behavioral effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review. Sports Med. 1990;10:303–37.10.2165/00007256-199010050-00003Search in Google Scholar PubMed

[45] Anderson RA, Bancroft J, Wu FC. The effects of exogenous testosterone on sexuality and mood of normal men. J Clin Endocrinol Metab. 1992;75:1503–7.10.1210/jcem.75.6.1464655Search in Google Scholar

[46] Okun MS, Fernandez HH, Rodriguez RL, Romrell J, Suelter M, Munson S, et al. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Arch Neurol. 2006;63:729–35.10.1001/archneur.63.5.729Search in Google Scholar

[47] Sih R, Morley JE, Kaiser FE, Perry 3rd HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997;82:1661–7.10.1210/jcem.82.6.3988Search in Google Scholar

[48] Dobs AS, Cofrancesco J, Nolten WE, Danoff A, Anderson R, Hamilton CD, et al. The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection. Am J Med. 1999;107:126–32.10.1016/S0002-9343(99)00193-XSearch in Google Scholar

[49] Janowksy JS, Oviatt SK, Orwoll ES. Testosterone influences spatial cognition in older men. Behavioral Neurosci. 1994;108:325–32.10.1037/0735-7044.108.2.325Search in Google Scholar

[50] Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1–7.10.1056/NEJM199607043350101Search in Google Scholar

[51] Tricker R, Casaburi R, Storer TW, Clevenger B, Berman N, Shirazi A, et al. The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men – a clinical research center study. J Clin Endocrinol Metab. 1996;81:3754–8.10.1210/jcem.81.10.8855834Search in Google Scholar

[52] O’Connor DB, Archer J, Hair WM, Wu FC. Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men. Physiol Behav. 2002;75:557–66.10.1016/S0031-9384(02)00647-9Search in Google Scholar

[53] Kunelius P, Lukkarinen O, Hannuksela ML, Itkonen O, Tapanainen JS. The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study. J Clin Endocrinol Metab. 2002;87:1467–72.10.1210/jcem.87.4.8138Search in Google Scholar PubMed

[54] Haren MT, Wittert GA, Chapman IM, Coates P, Morley JE. Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas. 2005;50:124–33.10.1016/j.maturitas.2004.05.002Search in Google Scholar PubMed

[55] Maki PM, Ernst M, London ED, Mordecai KL, Perschler P, Durso SC, et al. Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab. 2007;92:4107–14.10.1210/jc.2006-1805Search in Google Scholar PubMed

[56] Reddy P, White CM, Dunn AB, Moyna NM, Thompson PD. The effect of testosterone on healthrelated quality of life in elderly males – a pilot study. J Clin Pharm Ther. 2000;25:421–6.10.1046/j.1365-2710.2000.00309.xSearch in Google Scholar PubMed

[57] Zhou JN, Riemersma RF, Unmehopa UA, Hoogendijk WJ, van Heerikhuize JJ, Hofman MA, et al. Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch Gen Psychiatry. 2001;58:655–62.10.1001/archpsyc.58.7.655Search in Google Scholar PubMed

[58] Kruijver FP, Swabb DF. Sex hormone receptors are present in the human suprachiasmatic nucleus. Neuroendocrinology. 2002;75:296–305.10.1159/000057339Search in Google Scholar PubMed

[59] Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, et al. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart. 2004;90:871–6.10.1136/hrt.2003.021121Search in Google Scholar PubMed PubMed Central

[60] Jockenhövel F, Minnemann T, Schubert M, Freude S, Hübler D, Schumann C, et al. Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood. Aging Male. 2009;12:113–8.10.3109/13685530903322858Search in Google Scholar PubMed

[61] Traish AM. Benefits and health implications of testosterone therapy in men with testosterone deficiency. Sex Med Rev. 2018;6:86–105.10.1016/j.sxmr.2017.10.001Search in Google Scholar PubMed

[62] O’Carroll R, Shapiro C, Bancroft J. Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose. Clin Endocrinol (Oxf). 1985;23:527–38.10.1111/j.1365-2265.1985.tb01113.xSearch in Google Scholar PubMed

[63] Khera M. Male hormones and men’s quality of life. Curr Opin Urol. 2016;26:152–7.10.1097/MOU.0000000000000256Search in Google Scholar PubMed

[64] Tong S-F, Ng C-J, Lee B-C, Lee V-KM, Khoo E-M, Lee E-G, et al. Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial. Asian J Androl. 2012;14:606–11.10.1038/aja.2011.178Search in Google Scholar PubMed PubMed Central

[65] Wahjoepramono EJ, Asih PR, Aniwiyanti V, Taddei K, Dhaliwal SS, Fuller SJ, et al. The effects of testosterone supplementation on cognitive functioning in older men. CNS Neurol Disord Drug Targets. 2016;15:337–43.10.2174/1871527315666151110125704Search in Google Scholar PubMed PubMed Central

[66] Pexman-Fieth C, Behre HM, Morales A, Kan-Dobrosky N, Miller MG. A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. Aging Male. 2014;17:1–11.10.3109/13685538.2013.858113Search in Google Scholar PubMed PubMed Central

[67] Nian Y, Ding M, Hu S, He H, Cheng S, Yi L, Li Y, Wang Y. Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials. Andrologia. 2017;e12630:1–7.10.1111/and.12630Search in Google Scholar PubMed

[68] Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, et al. Lessons from the testosterone trials. Endocr Rev. 2018;39:369–86.10.1210/er.2017-00234Search in Google Scholar PubMed PubMed Central

[69] Cherrier MM, Craft S, Matsumoto AH. Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. J Androl. 2003;24:568–76.10.1002/j.1939-4640.2003.tb02708.xSearch in Google Scholar PubMed

[70] Cherrier MM. Androgens and cognitive function. J Endocrinol Invest. 2005;28(3 Suppl):65–75.Search in Google Scholar

[71] Cherrier MM, Anderson K, Shofer J, Millard S, Matsumoto AM. Testosterone treatment of men with mild cognitive impairment and low testosterone levels. Am J Alzheimers Dis Other Demen. 2015;30:421–30.10.1177/1533317514556874Search in Google Scholar PubMed

[72] Tan X, Shen F, Dong WL, Yang Y, Chen G. The role of hydrogen in Alzheimer’s disease. Med Gas Res. 2019;8:176–80.10.4103/2045-9912.248270Search in Google Scholar PubMed PubMed Central

[73] Ford AH, Yeap BB, Flicker L, Hankey GJ, Chubb SA, Handelsman DJ, et al. Prospective longitudinal study of testosterone and incident depression in older men: the Health in Men Study. Psychoneuroendocrinol. 2016; 64:57–65.10.1016/j.psyneuen.2015.11.012Search in Google Scholar PubMed

[74] Vartolomei MD, Kimura S, Vartolomei L, Shariat SF. Systematic review of the impact of testosterone replacement therapy on depression in patients with late-onset testosterone deficiency. Eur Urol Focus. 2018; DOI: 10.1016/j.euf.2018.07.006.10.1016/j.euf.2018.07.006Search in Google Scholar PubMed

[75] Elliott J, Kelly SE, Millar AC, Peterson J, Chen L, Johnston A, et al. Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis. Br Med J Open. 2017;7:e015284.10.1136/bmjopen-2016-015284Search in Google Scholar

[76] Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, and Wilkinson P. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med. 2013;10:1612–27.10.1111/jsm.12146Search in Google Scholar PubMed

[77] Miclea A, Miclea M, Pistor M, Stegmayer K, Hoepner R. Intramuscular testosterone supplementation ameliorates depression in hypogonadal men: a retrospective study in an outpatient department. Pharmacopsychiatry. 2018;51:257–62.10.1055/s-0043-125214Search in Google Scholar PubMed

[78] Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract. 2009;15:289–305.10.1097/01.pra.0000358315.88931.fcSearch in Google Scholar PubMed

[79] Walther A, Breidenstein J, Miller R. Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis. J Am Med Assoc Psychiatry. 2019;76:31–40.10.1001/jamapsychiatry.2018.2734Search in Google Scholar

[80] Westley CJ, Amdur RL, Irwig MS. High rates of depression and depressive symptoms among men referred for border-line testosterone levels. J Sex Med. 2015;12:1753–60.10.1111/jsm.12937Search in Google Scholar

[81] Chichinadze KN, Domianidze TR, Matitaishvili TTs, Chichinadze NK, Lazarashvili AG. Possible relation of plasma testosterone level to aggressive behavior of male prisoners. Bull Exp Biol Med. 2010;149:7–9.10.1007/s10517-010-0861-zSearch in Google Scholar

[82] Derntl B, Windischberger C, Robinson S, Kryspin-Exner I, Gur RC, Moser E, et al. Amygdala activity to fear and anger in healthy young males is associated with testosterone. Psychoneuroendocrinology. 2009;34:687–93.10.1016/j.psyneuen.2008.11.007Search in Google Scholar

[83] Hermans EJ, Ramsey NF, van Honk J. Exogenous testosterone enhances responsiveness to social threat in the neural circuitry of social aggression in humans. Biol Psychiatry. 2008;63:263–70.10.1016/j.biopsych.2007.05.013Search in Google Scholar

[84] Mazur A. Biosocial models of deviant behavior among male army veterans. Biol Psychol. 1995;41:271–93.10.1016/0301-0511(95)05138-4Search in Google Scholar

[85] Wirth MM, Schultheiss OC. Basal testosterone moderates responses to anger faces in humans. Physiol Behav. 2007;90:496–505.10.1016/j.physbeh.2006.10.016Search in Google Scholar

[86] Morley JE. Testosterone and behavior. Clin Geriatr Med. 2003;19:605–16.10.1016/S0749-0690(02)00106-4Search in Google Scholar

[87] Archer J. Testosterone and human aggression: an evaluation of the challenge hypothesis. Neurosci Biobehav Rev. 2006;30:319–45.10.1016/j.neubiorev.2004.12.007Search in Google Scholar PubMed

[88] Batrinos ML. Testosterone and aggressive behavior in man. Int J Endocrinol Metab. 2012;10:563–8.10.5812/ijem.3661Search in Google Scholar PubMed PubMed Central

[89] Carré JM, Mehta PH. Importance of considering testosterone-cortisol interactions in predicting human aggression and dominance. Aggress Behav. 2011;37:489–91.10.1002/ab.20407Search in Google Scholar

[90] Pope HG Jr, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry. 2000;57:133–40.10.1001/archpsyc.57.2.133Search in Google Scholar

[91] Mazur A, Booth A. Testosterone and dominance in men. Behav Brain Sci. 1998;21:353–63.10.1017/S0140525X98001228Search in Google Scholar

[92] Archer J. The influence of testosterone on human aggression. Brit J Psychol. 1991;82:1–28.10.1111/j.2044-8295.1991.tb02379.xSearch in Google Scholar

[93] Albert D, Walsh M, Jonik R. Aggression in humans: what is its biological foundation? Neurosci Biobehav Rev. 1994;17:405–25.10.1016/S0149-7634(05)80117-4Search in Google Scholar

[94] Carré JM, Geniole SN, Ortiz TL, Bird BM, Videto A, Bonin PL. Exogenous testosterone rapidly increases aggressive behavior in dominant and impulsive men. Biol Psychiatry. 2017;82:249–56.10.1016/j.biopsych.2016.06.009Search in Google Scholar PubMed

[95] Carré JM, Archer J. Testosterone and human behavior: the role of individual and contextual variables. Curr Opin Psychol. 2018;19:149–53.10.1016/j.copsyc.2017.03.021Search in Google Scholar PubMed

[96] Coates JM, Herbert J. Endogenous steroids and financial risk taking on a London trading floor. Proc Natl Acad Sci USA. 2008;105:6167–72.10.1073/pnas.0704025105Search in Google Scholar PubMed PubMed Central

[97] Cueva C, Roberts RE, Spencer T, Rani N, Tempest M, Tobler PN, et al. Cortisol and testosterone increase financial risk taking and may destabilize markets. Sci Rep. 2015;5:11206.10.1038/srep11206Search in Google Scholar PubMed PubMed Central

[98] Cueva C, Roberts RE, Spencer TJ, Rani N, Tempest M, Tobler PN, et al. Testosterone administration does not affect men’s rejections of low ultimatum game offers or aggressive mood. Horm Behav. 2017;87:1–7.10.1016/j.yhbeh.2016.09.012Search in Google Scholar PubMed

[99] Määttänen I, Jokela M, Hintsa T, Firtser S, Kähönen M, Jula A, et al. Testosterone and temperament traits in men: longitudinal analysis. Psychoneuroendocrinology. 2013;38:2243–8.10.1016/j.psyneuen.2013.04.009Search in Google Scholar PubMed

[100] Tsuchimine S, Kaneda A, Nakamura K, Yasui-Furukori N. The relationships between androgens and novelty seeking in healthy Japanese men. Psychiatry Res. 2015;225:175–8.10.1016/j.psychres.2014.11.013Search in Google Scholar PubMed

[101] Eisenegger C, Kumsta R, Naef M, Gromoll J, Heinrichs M. Testosterone and androgen receptor gene polymorphism are associated with confidence and competitiveness in men. Horm Behav. 2017;92:93–102.10.1016/j.yhbeh.2016.09.011Search in Google Scholar PubMed

[102] Geniole SN, Bird BM, Ruddick EL, Carré JM. Effects of competition outcome on testosterone concentrations in humans: an updated meta-analysis. Horm Behav. 2017;92:37–50.10.1016/j.yhbeh.2016.10.002Search in Google Scholar PubMed

[103] Casto KV, Edwards DA. Testosterone, cortisol, and human competition. Horm Behav. 2016;82:21–37.10.1016/j.yhbeh.2016.04.004Search in Google Scholar PubMed

[104] Rahman F, Christian HC. Non-classical actions of testosterone: an update. Trends Endocrinol Metab. 2007;18:371–8.10.1016/j.tem.2007.09.004Search in Google Scholar PubMed

[105] Carré JM, Olmstead NA. Social neuroendocrinology of human aggression: examining the role of competition-induced testosterone dynamics. Neuroscience. 2015;286:171–86.10.1016/j.neuroscience.2014.11.029Search in Google Scholar PubMed

[106] Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146:1141–50.10.1001/archdermatol.2010.256Search in Google Scholar PubMed

[107] Irwig MS. Persistent sexual and nonsexual adverse effects of Finasteride in younger men. Sex Med Rev. 2014;2:24–35.10.1002/smrj.19Search in Google Scholar PubMed

[108] Gupta AK, Charrette X. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride. J Dermatol Treat. 2014;25:156–61.10.3109/09546634.2013.813011Search in Google Scholar PubMed

[109] Williams B, Ospina JP, Jalilianhasanpour R, Fricchione GL, Perez DL. Fearful attachment linked to childhood abuse, alexithymia, and depression in motor functional neurological disorders. Neuropsychiatry Clin Neurosci. 2019;31:65–9.10.1176/appi.neuropsych.18040095Search in Google Scholar PubMed PubMed Central

[110] Thomas HN, Neal-Perry GS, Hess R. Female sexual function at midlife and beyond. Obstet Gynecol Clin North Am. 2018;45:709–22.10.1016/j.ogc.2018.07.013Search in Google Scholar PubMed PubMed Central

[111] Meston CM, Stanton AM. Understanding sexual arousal and subjective-genital arousal desynchrony in women. Nat Rev Urol. 2019;16:107–20.10.1038/s41585-018-0142-6Search in Google Scholar PubMed